期刊文献+

人脑胶质瘤逃避免疫监视机制的研究 被引量:2

Mechanism of Evading Surveillance in Gliomas
下载PDF
导出
摘要 为研究胶质瘤逃避免疫监视的机制,检测了胶质瘤体外细胞系培养上清(SN)抗PHA-P刺激正常人及胶质瘤患者外周血淋巴细胞增殖的作用。证实了胶质瘤可自分泌免疫抑制因子。经抗TGFβ2单抗中和SN试验,TGFβ2免疫组化染色及Northern杂交进一步表明该因子主要成分为TGFβ2并对胶质瘤患者血浆皮质醇,生长激素及儿茶酚胺含量及细胞免疫功能进行检测,发现血浆去甲肾上腺素显著降低,其水平与CD8亚群%呈负相关,与CD4/CD8比值及淋巴细胞增殖率呈正相关。初步提示存在胶质瘤的情况下,神经-免疫调控紊乱,可能起着抑制性调节作用。 The effect of supernatant seperated from cultured media of malignant glioma cell lines on the proliferation of peripheral blood lymphocytes (PBL)from healthy subjects and patients with glioma activated by mitogen PHA-P were studied. It was found that the glioma cells could secrete a T-cell supressor factor in an autocrine fashion which was identified further as the transforming growth factor B2. In addition,the plasma cortisol,growth hormone and catecholamine as well as the cellular immunity of patients with glioma were determined. It was demonstrated that the plasma level of norepinephrine in glioma patients was significantly declined and correlated well with the suppression of cellular immunity themselves. This finding has not been reported previously and suggests that the neuroimmuno-modulation may be disturbed in the presence of cerebral glioma.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1997年第6期435-439,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金
关键词 脑肿瘤 胶质瘤 细胞免疫 免疫抑制因子 Clioma Cellular immunity immune suppressor factor TGFβ_2 Neuroimmuno-modulation
  • 相关文献

参考文献6

  • 1王淑兰,天津医药,1996年,24卷,416页
  • 2林彤,中华神经外科杂志,1992年,8卷,256页
  • 3浦佩玉,中华神经外科杂志,1992年,8卷,28页
  • 4金冬雁,分子克隆实验指南(第2版),1992年,363页
  • 5林雯,中华神经外科杂志,1990年,6卷,增刊,42页
  • 6李求是,中国免疫学杂志,1986年,2卷,371页

同被引文献27

  • 1柳再明,雷霆,牛洪泉,董芳永,董震,王煜,薛德麟.肿瘤抗原致敏树突状细胞治疗胶质瘤的实验研究[J].肿瘤防治研究,2004,31(8):461-463. 被引量:2
  • 2Schuler G,Steinman RM.Dendritic cells as adjuvants for immune-mediated resistance to tumors.J Exp Med,1997,186:11831.
  • 3Legler JM,Ries LA,Smith MA,et al.Cancer surveillance series[corrected]:brain and other central nervous system cancers.Recent trends in incidence and mortality.J Natl Cancer Inst,1999,91:1382-1390.
  • 4Hamburger AB,Crotty LE,Archer GE,et al.Bone marrowderived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.J Neuroimmunol,2000,103:16-25.
  • 5Chi DD,Merchant RE,Rand R,et al.Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.Am J Pathol,1997,150:2143-2152.
  • 6Reardon DA,Akabani G,Coleman RE,et al.Phase Ⅱ trial of murine (131) Ⅰ-labeled antitenascin monoclonal antibody 81C6administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.J Clin Oncol,2002,20:1389-1397.
  • 7Steinman RM,Lustig DS,Cohn ZA.Identification of a novel cell type in peripheral lymphoid organs of mice.3.Functional properties in vivo.J Exp Med,1974,139:1431-1445.
  • 8Hart DN,Hill GR.Dendritic cell immunotherapy for cancer:Application to low-grade lymphoma and multiply myeloma.Immunol Cell Biol,1999,77:451-459.
  • 9Kock F,Heufler C,Kanpgen E,et al.Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture,but in contrast to granulocyte/macrophage colony2stimulating factor,without inducing their functional maturation.J Exp Med,1990,171:159-171.
  • 10Yamanaka R,Yajima N,Abe T,et al.Dendritic cell-based glioma immunotherapy.J Oncol,2003,23:5-15

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部